Andrew Ashe - President, Chief Operating Officer at Verve Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Chief Operating Officer
Stock Symbol
VERV on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Andrew Ashe - trading volume in the past year for Verve Therapeutics, Inc.

Holdings reported by Andrew Ashe for Verve Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 343K $2.14M $6.26 May 14, 2024 Direct
Restricted Stock Units 36K $360K $10.00 Feb 14, 2024 Direct Common Stock
Stock Option (right to buy) 150K Feb 14, 2024 Direct Common Stock

Transactions reported by Andrew Ashe for Verve Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.